Home > Insider Trading > Filing (0001209191-22-062125)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1160308	Savara Inc	SVRA	Pharmaceutical Preparations (2834)	841318182

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1283292	A David Ramsay	6836 Bee Cave Road Building Iii, Suite 201 Austin TX 78746		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-16	341	$1.50	1,946,593	No	4	P	Direct
Common Stock	Acquisiton	2022-12-19	40,719	$1.49	1,987,312	No	4	P	Direct
Common Stock	Acquisiton	2022-12-20	13,830	$1.50	2,001,142	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price is a weighted average purchase price. The purchase prices ranged from $1.47 to $1.52. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
The price is a weighted average purchase price. The purchase prices ranged from $1.485 to $1.53. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.